Literature DB >> 2429732

Mammalian optic nerve fibers display two pharmacologically distinct potassium channels.

J D Kocsis, T R Gordon, S G Waxman.   

Abstract

A suction electrode recording technique was used to study action potential characteristics of rat optic nerve fibers. Two pharmacologically distinct potassium channels are described. One is sensitive to 4-aminopyridine (4-AP) and the other to tetraethylammonium (TEA). 4-AP application leads to a substantial broadening of the optic nerve action potential, but TEA does not. 4-AP application also elicits a TEA-sensitive post-spike positivity, i.e. an intracellular hyperpolarization. From these results we suggest that the 4-AP-sensitive channel, not the TEA-sensitive channel, is primarily responsible for action potential repolarization of mammalian optic nerve fibers.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2429732     DOI: 10.1016/0006-8993(86)90040-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

1.  Determinants of excitability at transition zones in Kv1.1-deficient myelinated nerves.

Authors:  L Zhou; A Messing; S Y Chiu
Journal:  J Neurosci       Date:  1999-07-15       Impact factor: 6.167

2.  Current-clamp analysis of a time-dependent rectification in rat optic nerve.

Authors:  D L Eng; T R Gordon; J D Kocsis; S G Waxman
Journal:  J Physiol       Date:  1990-02       Impact factor: 5.182

3.  Autophosphorylated CaMKII Facilitates Spike Propagation in Rat Optic Nerve.

Authors:  Gloria J Partida; Anna Fasoli; Alex Fogli Iseppe; Genki Ogata; Jeffrey S Johnson; Vithya Thambiaiyah; Christopher L Passaglia; Andrew T Ishida
Journal:  J Neurosci       Date:  2018-08-03       Impact factor: 6.167

4.  A method for reducing animal use whilst maintaining statistical power in electrophysiological recordings from rodent nerves.

Authors:  Laura R Rich; Jonathan A Patrick; Margaret A Hamner; Bruce R Ransom; Angus M Brown
Journal:  Heliyon       Date:  2020-06-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.